Munenobu Kashiwa & Ryo Matsushita. (2021). Cost-effectiveness of preemptive skin treatment to prevent skin-toxicity caused by panitumumab in third-line therapy for KRAS wild type metastatic colorectal cancer in Japan. BMC.
Chicago Style (17th ed.) CitationMunenobu Kashiwa and Ryo Matsushita. Cost-effectiveness of Preemptive Skin Treatment to Prevent Skin-toxicity Caused by Panitumumab in Third-line Therapy for KRAS Wild Type Metastatic Colorectal Cancer in Japan. BMC, 2021.
MLA (9th ed.) CitationMunenobu Kashiwa and Ryo Matsushita. Cost-effectiveness of Preemptive Skin Treatment to Prevent Skin-toxicity Caused by Panitumumab in Third-line Therapy for KRAS Wild Type Metastatic Colorectal Cancer in Japan. BMC, 2021.
Warning: These citations may not always be 100% accurate.